Published In
European Journal of Rheumatology
Volume 12 · Issue 4
Pages: 1-2
History
Published Online: December 5, 2025
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © 2025 European Journal of Rheumatology
Tatsuya Suwabe
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Masayuki Yamanouchi
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Yoshifumi Ubara
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Naoki Sawa
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Suwabe, T., Yamanouchi, M., Ubara, Y., & Sawa, N. (2025). Long-Term Effect and Safety of Tocilizumab on Severe Adult-Onset Still’s Disease Accompanied by Thrombotic Thrombocytopenic Purpura. European Journal of Rheumatology, 12(4), 1–2. https://doi.org/10.5152/eurjrheum.2025.0029
Full Text
Full Text PDF
Full Text PDF
Abstract
Cite this article as: Suwabe T, Yamanouchi M, Ubara Y, Sawa N. Long-term effect and safety of tocilizumab on severe adult-onset Still’s disease accompanied by thrombotic thrombocytopenic purpura. Eur J Rheumatol. 2025, 12(4), 0029, doi: 10.5152/eurjrheum.2025.25029.
Article Info
Published In
Journal
European Journal of Rheumatology
Volume / Issue
Volume 12 · Issue 4
Pages
1-2
History
Published Online
December 5, 2025
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright
Copyright (c) 2025 European Journal of Rheumatology
Affiliations
Tatsuya Suwabe
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Masayuki Yamanouchi
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Yoshifumi Ubara
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Naoki Sawa
Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan ; Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Cite this Article
Suwabe, T., Yamanouchi, M., Ubara, Y., & Sawa, N. (2025). Long-Term Effect and Safety of Tocilizumab on Severe Adult-Onset Still’s Disease Accompanied by Thrombotic Thrombocytopenic Purpura. European Journal of Rheumatology, 12(4), 1–2. https://doi.org/10.5152/eurjrheum.2025.0029
Outlines